Pulmonary Circulation Q2 Unclaimed
Pulmonary Circulation is a journal indexed in SJR in Pulmonary and Respiratory Medicine with an H index of 59. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1800 €. The scope of the journal is focused on vascular disease, cardiopulmonary disease, pulmonary hypertension, lung injury, right heart failure. It has an SJR impact factor of 0,804 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,804.
Type: Journal
Type of Copyright: CC BY-NC
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
1800 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,804
SJR Impact factor59
H Index147
Total Docs (Last Year)441
Total Docs (3 years)4601
Total Refs1011
Total Cites (3 years)399
Citable Docs (3 years)2.11
Cites/Doc (2 years)31.3
Ref/DocOther journals with similar parameters
Respiration; international review of thoracic diseases Q2
Respiration Q2
Chronic Respiratory Disease Q2
BMC Pulmonary Medicine Q2
Journal of Breath Research Q2
Compare this journals
Aims and Scope
Best articles by citations
The Pulmonary Vascular Research Institute and Its Future
View moreThe WHO Classification of Pulmonary Hypertension: A Case-Based Imaging Compendium
View moreArginine Metabolic Endotypes in Pulmonary Arterial Hypertension
View moreRole Played by Paxillin and Paxillin Tyrosine Phosphorylation in Hepatocyte Growth Factor/Sphingosine-1-Phosphate-Mediated Reactive Oxygen Species Generation, Lamellipodia Formation, and Endothelial Barrier Function
View moreVascular Endothelial Growth Factor Receptor 3 Signaling Contributes to Angioobliterative Pulmonary Hypertension
View moreEffects of Ranolazine on Exercise Capacity, Right Ventricular Indices, and Hemodynamic Characteristics in Pulmonary Arterial Hypertension: A Pilot Study
View morePulmonary Artery Denervation for Treatment of a Patient with Pulmonary Hypertension Secondary to Left Heart Disease
View moreActivation of the Unfolded Protein Response is Associated with Pulmonary Hypertension
View moreAcute Hemodynamic Effects of Nebulized Iloprost via the I-Neb Adaptive Aerosol Delivery System in Pulmonary Hypertension
View morePulmonary Capillary Hemangiomatosis: The Role of Invasive Cardiopulmonary Exercise Testing
View moreLeft Main Coronary Artery Compression in Pulmonary Arterial Hypertension
View moreEndothelial follistatin-like-1 regulates the postnatal development of the pulmonary vasculature by modulating BMP/Smad signaling
View moreBone Marrow-Derived Vascular Modulatory Cells in Pulmonary Arterial Hypertension
View moreEffects of Omeprazole and Aluminum Hydroxide/Magnesium Hydroxide on Riociguat Absorption
View moreTransient but Not Genetic Loss of miR-451 is Protective in the Development of Pulmonary Arterial Hypertension
View morePentraxin-3 and the Right Ventricle: The Multi-Ethnic Study of Atherosclerosis-Right Ventricle Study
View morePulmonary Circulation: A New Venue for Communicating Your Findings, Ideas and Perspectives
View moreCombination of Erythropoietin and Sildenafil Can Effectively Attenuate Hypoxia-Induced Pulmonary Hypertension in Mice
View moreComputed Tomography Correlates with Cardiopulmonary Hemodynamics in Pulmonary Hypertension in Adults with Sickle Cell Disease
View moreOxidative-Stress Biomarkers in Patients with Pulmonary Hypertension
View moreChallenges in the development of chronic pulmonary hypertension models in large animals
View moreNever Too Old for Congenital Heart Disease: Sinus Venosus Atrial Septal Defect with Anomalous Pulmonary Venous Return in an Octogenarian
View moreExpression of Mutant BMPR-II in Pulmonary Endothelial Cells Promotes Apoptosis and a Release of Factors that Stimulate Proliferation of Pulmonary Arterial Smooth Muscle Cells
View moreIdiopathic and Heritable PAH Perturb Common Molecular Pathways, Correlated with Increased MSX1 Expression
View more
Comments